Translating neurogenomics into new medicines

Biological Psychiatry

Volumn 79, Issue 8, 2016, Pages 650-656

  Wendland, Jens R ^a   Ehlers, Michael D ^a  

^a PFIZER INC   (United States)

Author keywords

Brain disorders; Circuits; Genes; Genomics; GWAS; Human genetics; Psychiatry; Translational medicine

Indexed keywords

BRAIN DISEASE; DISEASE SEVERITY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOMICS; MEDICINE; NEUROGENOMICS; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH; BRAIN DISEASES; GENETICS; HUMAN; PROCEDURES;

BRAIN DISEASES; GENOMICS; HUMANS; PRECISION MEDICINE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84961187134     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.04.027     Document Type: Review

References (62)

1. Hyman SE (2012): Revolution stalled. Sci Transl Med 4:155cm111.
2. S.A. McCarroll, and S.E. Hyman Progress in the genetics of polygenic brain disorders: Significant new challenges for neurobiology Neuron 80 2013 578 587
3. R.L. Buckner, F.M. Krienen, and B.T. Yeo Opportunities and limitations of intrinsic functional connectivity MRI Nat Neurosci 16 2013 832 837
4. N. Risch, and K. Merikangas The future of genetic studies of complex human diseases Science 273 1996 1516 1517
5. F. Dudbridge, and A. Gusnanto Estimation of significance thresholds for genomewide association scans Genet Epidemiol 32 2008 227 234
6. Panagiotou OA, Ioannidis JP, Genome-Wide Significance Project (2012): What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol 41:273-286.
7. F. Prinz, T. Schlange, and K. Asadullah Believe it or not: How much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10 2011 712
8. S. Perrin Preclinical research: Make mouse studies work Nature 507 2014 423 425
9. Krystal JH, State MW (2014): Psychiatric disorders: Diagnosis to therapy. Cell 157:201-214.
10. K.S. Kendler What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn Mol Psychiatry 18 2013 1058 1066
11. Sullivan PF, Daly MJ, OEDonovan M (2012): Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet 13:537-551.
12. N. Craddock, and P. Sklar Genetics of bipolar disorder Lancet 381 2013 1654 1662
13. Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium S. Ripke, N.R. Wray, C.M. Lewis, S.P. Hamilton, M.M. Weissman, and et al. A mega-analysis of genome-wide association studies for major depressive disorder Mol Psychiatry 18 2013 497 511
14. J.C. Lambert, C.A. Ibrahim-Verbaas, D. Harold, A.C. Naj, R. Sims, C. Bellenguez, A.L. DeStafano, and et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for AlzheimerEs disease Nat Genet 45 2013 1452 1458
15. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature 511 2014 421 427
16. Psychosis Endophenotypes International Consortium, Wellcome Trust Case-Control Consortium E. Bramon, M. Pirinen, A. Strange, K. Lin, and et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation Biol Psychiatry 75 2014 386 397
17. W.G. Iacono, U. Vaidyanathan, S.I. Vrieze, and S.M. Malone Knowns and unknowns for psychophysiological endophenotypes: Integration and response to commentaries Psychophysiology 51 2014 1339 1347
18. D. Goldman The missing heritability of behavior: The search continues Psychophysiology 51 2014 1327 1328
19. Cross-Disorder Group of the Psychiatric Genomics Consortium S.H. Lee, S. Ripke, B.M. Neale, S.V. Faraone, SM Purcell, and et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs Nat Genet 45 2013 984 994
20. Cross-Disorder Group of the Psychiatric Genomics Consortium, Genetic Risk Outcome of Psychosis Consortium Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis Lancet 381 2013 1371 1379
21. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 5th ed. 2013 American Psychiatric Association Washington, DC
22. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 American Psychiatric Association Washington, DC
23. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992 World Health Organization Geneva
24. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, and et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
25. M.N. Samtani, M. Farnum, V. Lobanov, E. Yang, N. Raghavan, A. Dibernardo, and et al. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative J Clin Pharmacol 52 2012 629 644
26. M.N. Samtani, N. Raghavan, Y. Shi, G. Novak, M. Farnum, V. Lobanov, and et al. Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes Br J Clin Pharmacol 75 2013 146 161
27. D.G. Crenshaw, W.K. Gottschalk, M.W. Lutz, I. Grossman, A.M. Saunders, J.R. Burke, and et al. Using genetics to enable studies on the prevention of Alzheimer's disease Clin Pharmacol Ther 93 2013 177 185
28. L. Santarelli An audience with... Luca Santarelli. Interview by Alexandra Flemming Nat Rev Drug Discov 12 2013 14 15
29. H. Anderson-Schmidt, L. Adler, C. Aly, I.G. Anghelescu, M. Bauer, J. Baumgartner, and et al. The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients Eur Arch Psychiatry Clin Neurosci 263 2013 695 701
30. K. Demyttenaere, and J. De Fruyt Getting what you ask for: On the selectivity of depression rating scales Psychother Psychosom 72 2003 61 70
31. A.M. Mortimer Symptom rating scales and outcome in schizophrenia Br J Psychiatry Suppl 50 2007 s7 14
32. H.G. Eichler, B. Bloechl-Daum, E. Abadie, D. Barnett, F. Konig, and S. Pearson Relative efficacy of drugs: An emerging issue between regulatory agencies and third-party payers Nat Rev Drug Discov 9 2010 277 291
33. K.E. Tansey, M. Guipponi, X. Hu, E. Domenici, G. Lewis, A. Malafosse, and et al. Contribution of common genetic variants to antidepressant response Biol Psychiatry 73 2013 679 682
34. E. Murphy, and F.J. McMahon Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations Discov Med 16 2013 113 122
35. B.N. Cuthbert, and T.R. Insel Toward the future of psychiatric diagnosis: The seven pillars of RDoC BMC Med 11 2013 126
36. T.D. Wager, and E.E. Smith Neuroimaging studies of working memory: A meta-analysis Cogn Affect Behav Neurosci 3 2003 255 274
37. S.L. Rauch, L.M. Shin, and C.I. Wright Neuroimaging studies of amygdala function in anxiety disorders Ann N Y Acad Sci 985 2003 389 410
38. J.W. Buckholtz, and A. Meyer-Lindenberg Psychopathology and the human connectome: Toward a transdiagnostic model of risk for mental illness Neuron 74 2012 990 1004
39. M.J. Millan, Y. Agid, M. Brune, E.T. Bullmore, C.S. Carter, N.S. Clayton, and et al. Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy Nat Rev Drug Discov 11 2012 141 168
40. A. Papassotiropoulos, C. Gerhards, A. Heck, S. Ackermann, A. Aerni, N. Schicktanz, and et al. Human genome-guided identification of memory-modulating drugs Proc Natl Acad Sci U S A 110 2013 E4369 E4374
41. Z. Wang, M. Gerstein, and M. Snyder RNA-Seq: A revolutionary tool for transcriptomics Nat Rev Genet 10 2009 57 63
42. GTEx Consortium The Genotype-Tissue Expression (GTEx) project Nat Genet 45 2013 580 585
43. I. Voineagu, X. Wang, P. Johnston, J.K. Lowe, Y. Tian, S. Horvath, and et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology Nature 474 2011 380 384
44. Common Mind Consortium. Available at: http://commonmind.org/. Accessed April 24, 2014.
45. A.E. Jaffe, J. Shin, L. Collado-Torres, J.T. Leek, R. Tao, C. Li, and et al. Developmental regulation of human cortex transcription and its clinical relevance at single base resolution Nat Neurosci 18 2015 154 161
46. L. Jostins, S. Ripke, R.K. Weersma, R.H. Duerr, D.P. McGovern, K.Y. Hui, and et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
47. L. Jones, P.A. Holmans, M.L. Hamshere, D. Harold, V. Moskvina, D. Ivanov, and et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease PloS One 5 2010 e13950
48. C.R. Schubert, H.S. Xi, J.R. Wendland, and P O'Donnell Translating human genetics into novel treatment targets for schizophrenia. Neuron 84 2014 537 541
49. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv Drug Deliv Rev 46 2001 3 26
50. E.B. Fauman, B.K. Rai, and E.S. Huang Structure-based druggability assessment - identifying suitable targets for small molecule therapeutics Curr Opin Chem Biol 15 2011 463 468
51. P. Kochunov, and L.E. Hong Neurodevelopmental and neurodegenerative models of schizophrenia: White matter at the center stage Schizophr Bull 40 2014 721 728
52. E.T. Lim, P. Wurtz, A.S. Havulinna, P. Palta, T. Tukiainen, K. Rehnstrom, and et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population PLoS Geneti 10 2014 e1004494
53. P.H. St George-Hyslop Molecular genetics of Alzheimer's disease Biol Psychiatry 47 2000 183 199
54. T. Jonsson, J.K. Atwal, S. Steinberg, J. Snaedal, P.V. Jonsson, S. Bjornsson, and et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline Nature 488 2012 96 99
55. I. Splawski, K.W. Timothy, L.M. Sharpe, N. Decher, P. Kumar, R. Bloise, and et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism Cell 119 2004 19 31
56. C. Antzelevitch, G.D. Pollevick, J.M. Cordeiro, O. Casis, M.C. Sanguinetti, Y. Aizawa, and et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death Circulation 115 2007 442 449
57. A. Katsnelson Drug development: The modelling challenge Nature 508 2014 S8 S9
58. P.F. Sullivan The psychiatric GWAS consortium: Big science comes to psychiatry Neuron 68 2010 182 186
59. J.W. Scannell, A. Blanckley, H. Boldon, and B. Warrington Diagnosing the decline in pharmaceutical R&D efficiency Nat Rev Drug Discov 11 2012 191 200
60. T. Shimamura, M. Shiroishi, S. Weyand, H. Tsujimoto, G. Winter, V. Katritch, and et al. Structure of the human histamine H1 receptor complex with doxepin Nature 475 2011 65 70
61. Wikimedia Commons. Available at: http://commons.wikimedia.org/wiki/File:MRI-Location-Amygdala-up.png. Accessed April 24, 2014.
62. Wikimedia Commons. Available at: http://commons.wikimedia.org/wiki/File:H1-Receptor-with-Doxepin.png. Accessed April 24, 2014.